Galera Therapeutics Announces Presentation of Data from Phase 2b Clinical Trial of GC4419 at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

World News: . []

MALVERN Penn May 16 2018 GLOBE NEWSWIRE -- Galera Therapeutics Inc a clinical-stage biotechnology company developing drugs targeting oxygen metabolic pathways with the potential to transform cancer radiotherapy today announced that data from it...

More news and information about Galera Therapeutics, Inc.

Published By:

Globe Newswire: 22:05 GMT Wednesday 16th May 2018

Published: .

Search for other references to "galera" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us